about
Heterogeneous Pathology of Melasma and Its Clinical ImplicationsMelasma updateMechanisms regulating skin pigmentation: the rise and fall of complexion colorationEffect of 82% Lactic Acid in Treatment of MelasmaHyperpigmentation and melasma.Established treatments of skin hypermelanoses.A study comparing chemical peeling using modified Jessner's solution and 15% trichloroacetic Acid versus 15% trichloroacetic acid in the treatment of melasmaHydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation.Updates in the understanding and treatments of skin & hair disorders in women of colorA review of laser and light therapy in melasma.Dermatologic conditions in patients of color who are pregnantA cross-sectional, multicentric clinico-epidemiological study of melasma in India.Retrospective Analysis of Endemic Melasma Patients.Mometasone-based triple combination therapy in melasma: is it really safe?Cosmetic contact sensitivity in patients with melasma: results of a pilot study.Using a Hydroquinone/Tretinoin-based Skin Care System Before and After Electrodesiccation and Curettage of Superficial Truncal Basal Cell Carcinoma: A Multicenter, Randomized, Investigator-blind, Controlled Study of Short-term Healing.Melasma: a clinical and epidemiological reviewChemical peeling in ethnic/dark skin.Menopause and the skin.Topical tranexamic acid as a promising treatment for melasmaChemical peels for melasma in dark-skinned patients.A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian PatientsEvidence-based treatment for melasma: expert opinion and a review.Can you identify this condition? MelasmaA study on fractional erbium glass laser therapy versus chemical peeling for the treatment of melasma in female patientsTreatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser.Melasma: a clinico-epidemiological study of 312 casesSerum iron level, ferritin and total iron binding capacity level among nonpregnant women with and without melasma.Management of dyschromias in ethnic skin.On the etiology of contact/occupational vitiligo.Oral Tranexamic Acid with Fluocinolone-Based Triple Combination Cream Versus Fluocinolone-Based Triple Combination Cream Alone in Melasma: An Open Labeled Randomized Comparative Trial.Comparative study of 15% TCA peel versus 35% glycolic acid peel for the treatment of melasma.Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma.The Effect of Melasma on the Quality of Life in a Sample of Women Living in Singapore.Proposing Melasma Severity Index: A New, More Practical, Office-based Scoring System for Assessing the Severity of Melasma.Korean red ginseng powder in the treatment of melasma: an uncontrolled observational studyA clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment.IgM Chlamydia Trachomatis Antibodies in Cases of Melasma.The prevalence of melasma and its association with quality of life in adult male Latino migrant workers.Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety
P2860
Q26744829-978A8E74-6074-45DF-AF66-FFCDBC282272Q26852298-BAB177A4-773F-4FA1-B21B-0E23E8F80A4EQ28262877-F8BFC394-3297-47BC-9BA6-674DB93B83A3Q28828563-77CF405E-9BD2-4B33-8C07-9EFF3E9F5868Q30833725-11855BBC-CDA4-42E1-98CB-9A523CB36102Q33294994-2B0E0A54-BEE7-466C-B583-F69F9173E473Q33521898-70818095-C1EB-4792-B928-B6AFF00EEABEQ33629697-205FEEC5-A697-4A8A-AF84-4580EE52A141Q33640681-B1FBB58A-7217-4E84-B5AB-E232791B2394Q33641450-1BC73CBE-B2F7-40E0-ACD2-F97DDE169A16Q33641455-436F2402-7183-4951-95C8-D5CA34882A03Q33785078-BF1DD648-DA64-437D-A020-63E1957CF1D2Q33811223-30B88158-1779-45DD-BD61-D67BB61A7541Q33853724-86D40409-BD19-4A8F-9C12-8B67C9000B6CQ34009766-95E98535-1177-4AC2-AD1B-0FE250764FE3Q34074575-97A53D0D-B0BE-45AD-ACA9-6D67F061FE48Q34140514-97241EB1-655D-4A6A-AA14-7CD7B7C52E76Q34316918-D6020BE2-1AEB-4F3D-8B3B-E63F5D523AE8Q34328005-96A2DFAE-E7B7-4289-BB3F-D62D394D5D71Q34529832-32219307-60F9-4D3F-A7D8-32F3AE6945EBQ34573541-AAAF2E64-F9FD-4CD2-9F7D-282D1EDAAA44Q34573546-B2F62E6E-4037-4C14-8753-934096CA89EBQ34642576-B19D9586-5F00-40AD-B36A-EEEEDBFB72C7Q34654060-C011579B-E353-404D-97B6-DF988FB332A2Q35026969-DB55CA2A-ABC8-4B50-84DC-01467AEF9B3FQ35041861-EFB5D725-752F-4551-86B6-C9B651161A0BQ35228999-202150D9-29BF-4453-880C-D7805E09066AQ35744829-4DBA9C12-4006-4311-8242-F0F735F5D0EFQ35758241-DDE411C9-8421-4A47-8618-4FC169DC7D26Q35771681-9C4A1467-67C6-410E-B775-43D033C88103Q36147782-13B4A836-7CCD-462D-8D73-37B4433B1B0CQ36349539-B8049028-41CF-4C30-BCA1-DA0DA36894E8Q36529444-1A373CD7-0320-43D6-BDA7-9A3C86D91926Q36589019-34EC6EED-6068-427A-9313-D2627CEFD6E3Q36607258-74715E84-EB48-40C7-90E2-B498266366DCQ36860895-D75E07AB-DB62-4A24-965D-EA89285CCAF8Q36885944-FFCAD76A-564F-4E09-89C2-5A3773B05390Q37042824-A55B917B-E5D9-409D-AE5B-E92E36C4219FQ37052010-D43DC164-464B-495D-B779-D03266D2C14CQ37054324-DB056735-7ACC-4553-824C-CCBB992C284F
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Melasma. Etiologic and therapeutic considerations.
@ast
Melasma. Etiologic and therapeutic considerations.
@en
type
label
Melasma. Etiologic and therapeutic considerations.
@ast
Melasma. Etiologic and therapeutic considerations.
@en
prefLabel
Melasma. Etiologic and therapeutic considerations.
@ast
Melasma. Etiologic and therapeutic considerations.
@en
P1433
P1476
Melasma. Etiologic and therapeutic considerations.
@en
P2093
P E Grimes
P304
P356
10.1001/ARCHDERM.131.12.1453
P577
1995-12-01T00:00:00Z